Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.
Thoracic Cancer|November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancerShirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer|September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in ChinaXingxiang Pu, Chunwei Xu, Qian Wang, et al.
Thoracic Cancer|September 20, 2022
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in ChinaChunwei Xu, Lu Si, Wenxian Wang, et al.
Thoracic Cancer|March 16, 2023
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumorsChunwei Xu, Yongchang Zhang, Wenxian Wang, et al.
Thoracic Cancer|July 17, 2023
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesotheliomaQian Wang, Chunwei Xu, Wenxian Wang, et al.
Cancer Biology & Medicine|April 9, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alterationHuijing Feng, Yang Xia, Wenxian Wang, et al.
Global Medical Genetics|February 28, 2024
Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid TumorsChunwei Xu, Qian Wang, Dong Wang, et al.
Global Medical Genetics|November 25, 2024
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid TumorsChunwei Xu, Bin Lian, Juanjuan Ou, et al.
Innovation (Cambridge (Mass.))|November 12, 2024
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutationsWenxian Wang, Bin Lian, Chunwei Xu, et al.
Pageof 11